-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-09-04
A 2025 European Journal of Cell Biology study established a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into epithelial monolayers containing metabolically and transporter-active enterocytes, providing a more human-relevant platform for pharmacokinetic research.
-
MK-1775: Reading Checkpoint Assays Correctly
2026-09-03
MK-1775, a selective Wee1 kinase inhibitor, is more than a checkpoint-abrogation tool: it is a way to separate growth arrest from true cell killing in cancer assays. This guide combines Wee1 biology with the assay-interpretation framework developed by Schwartz to improve experimental design and translational relevance.
-
Chemerin–cNTS Signaling Raises Sympathetic Activity
2026-09-03
This 2024 study identifies a chemerin–CMKLR1–NADPH oxidase–superoxide pathway in the caudal nucleus tractus solitarius that increases renal sympathetic nerve activity, blood pressure, and heart rate. Its pharmacological comparison further indicates that the cardiovascular response depends on an NMDA-sensitive paraventricular nucleus relay rather than an AMPA/kainate-dependent mechanism.
-
2,2,2-Trichloroethanol in Protein Analysis
2026-09-02
2,2,2-Trichloroethanol is a small molecule biochemical reagent for protein electrophoresis and in-gel fluorescence workflows. Product identity, solubility, cold storage, and analytical boundaries are separated here from peer-reviewed dopamine transporter imaging evidence.
-
KDM4D–PI3K-Akt–Foxo1 Control of MSC Quiescence
2026-09-02
The 2024 study identifies an iron-sensitive epigenetic mechanism that regulates mesenchymal stem cell activation and bone homeostasis. It connects reduced KDM4D demethylase activity with H3K9me3 accumulation at the PIK3R3 promoter and downstream PI3K-Akt-Foxo1 signaling, providing a mechanistic framework for understanding iron deficiency-associated bone loss.
-
CUDC-907: Practical Cell-Based Workflow
2026-09-01
CUDC-907 (SKU A4097) is a dual PI3K and HDAC inhibitor for controlled studies of PI3K/AKT signaling, histone acetylation, cell-cycle distribution, and apoptosis in established cell models. This guide uses product-dossier values as starting points for in vitro research and does not support diagnostic, therapeutic, or clinical use.
-
3D Viability: From Staining to Translation
2026-09-01
A thought-leadership guide to using Calcein-AM and Propidium Iodide as mechanistically complementary readouts in 3D hydrogel research, with strategic guidance for microscopy, flow cytometry, cytotoxicity studies, and translational assay design.
-
hUC-MSCs Target PND Through β-NGF–SARM1 Signaling
2026-08-31
A 2026 study identifies a β-NGF–dependent STMN2/NMNAT2–SARM1–NF-κB axis through which human umbilical cord mesenchymal stem cells improve postoperative cognitive impairment in aged mice. Its combination of behavioral, pathological, proteomic, and pathway-perturbation evidence links reduced neuronal apoptosis and neuroinflammation with restored dendritic structure, while also defining important limitations for translation to human perioperative neurocognitive disorders.
-
10074-G5 Workflow for c-Myc Cancer Research
2026-08-31
Build a practical c-Myc inhibition workflow around 10074-G5, from DMSO stock preparation and dose response to apoptosis, cell-cycle, and pathway readouts. The approach connects mechanistic c-Myc/TERT/NFκB biology with translational cancer research while clearly separating product benchmarks from experiment-specific optimization.
-
Budesonide: From Inflammation to Lung Permeability
2026-08-30
Budesonide is an anti-inflammatory corticosteroid with value beyond conventional asthma inflammation models. This article explains how biomimetic chromatography and mass spectrometry can guide interpretation of pulmonary membrane behavior without confusing analytical permeability with biological efficacy.
-
GSK-923295: CENP-E Inhibitor Workflow Guide
2026-08-29
GSK-923295 provides a controlled chemical route to study CENP-E-dependent chromosome congression, mitotic arrest, and tumor-cell growth. This workflow guide connects biochemical potency with imaging, viability, centromere-architecture assays, and carefully interpreted colon cancer xenograft evidence.
-
Nanoplastics and MAPK/ERK Vascular Lipid Dysregulation
2026-08-28
A 2026 study shows that prenatal and lactational exposure to 100-nm polystyrene nanoplastics disrupts vascular lipid homeostasis in male mouse offspring and in MOVAS cells. The evidence supports a MAPK/ERK/UHRF1 pathway in this response, while also highlighting why developmental timing, sex, and pathway-specific controls are essential for interpreting nanoplastic cardiovascular toxicity.
-
Phagocytic Giant Cancer Macrophages in Blood
2026-08-28
The reference study presents circulating cancer-associated macrophage-like cells (CAMLs) as clinically informative polyploid giant cells rather than inert tumor debris. In a prospective, multi-institutional cohort, CAMLs correlated with disease progression and spread while displaying self-renewal, proangiogenic, and overlapping myeloid, epithelial, and endothelial features.
-
POx Lipids as PEG Alternatives in mRNA LNPs
2026-08-27
Holick and colleagues investigated poly(2-ethyl-2-oxazoline)-based lipids as substitutes for PEG-lipids in mRNA lipid nanoparticles. By varying polymer chain length and combining physicochemical, immunoreaction, transfection, and super-resolution microscopy analyses, the study identified a PEtOx-LNP formulation that outperformed the tested commercial PEG-lipid comparator in transfection-related measures.
-
MK-1775 Wee1 Kinase Inhibitor Workflows
2026-08-27
Build more informative MK-1775 experiments by pairing Wee1 pathway biomarkers with separate measures of growth inhibition and cell killing. This workflow guide covers checkpoint-abrogation assays, combination studies in p53-deficient models, dosing logic, and practical troubleshooting.